Smith Hayes Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Smith Hayes Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.51M	Buy	23,711 +751	+3%	+$47.4K	0.31%	91
2015 Q4	$1.58M	Buy	22,960 +23	+0.1%	+$1.52K	0.33%	88
2015 Q3	$1.36M	Sell	22,937 -326	-1%	-$20.7K	0.29%	98
2015 Q2	$1.55M	Sell	23,263 -1,252	-5%	-$82.5K	0.31%	98
2015 Q1	$1.58M	Sell	24,515 -2,930	-11%	-$183K	0.31%	95
2014 Q4	$1.62M	Buy	27,445 +1,571	+6%	+$88.6K	0.34%	92
2014 Q3	$1.32M	Buy	25,874 +81	+0.3%	+$4.05K	0.31%	100
2014 Q2	$1.25M	Sell	25,793 -9,389	-27%	-$463K	0.29%	105
2014 Q1	$1.83M	Buy	35,182 +6,899	+24%	+$367K	0.45%	69
2013 Q4	$1.5M	Buy	28,283 +398	+1%	+$20.3K	0.49%	63
2013 Q3	$1.29M	Buy	27,885 +2,428	+10%	+$107K	0.49%	63
2013 Q2	$1.14M	Buy	+25,457	New	+$1.11M	0.47%	71

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Smith Hayes Advisers's BMY Position: Q1 2016 in Review

Smith Hayes Advisers increased its Bristol-Myers Squibb (BMY) stake by 3.3% in Q1 2016, buying an estimated $47.4K and bringing the position to 23,711 shares worth $1.51M. The position accounts for 0.31% of the portfolio, ranked #91.

Smith Hayes Advisers first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.83M in Q1 2014. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Smith Hayes Advisers held 23,711 shares of Bristol-Myers Squibb worth $1.51M as of Q1 2016.
Smith Hayes Advisers bought 751 Bristol-Myers Squibb shares in Q1 2016, an estimated $47.4K.
Bristol-Myers Squibb made up 0.31% of Smith Hayes Advisers's portfolio in Q1 2016, its #91 holding.
Smith Hayes Advisers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
Smith Hayes Advisers's Bristol-Myers Squibb position peaked at $1.83M in Q1 2014.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.